TARA WILLIAMS-MATNEY: Open Payments
NPI 1417192543 · GRUNDY, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 39 payments from 12 companies in 2025. Trend: 2023 $953 · 2024 $1,142 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $176 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $160 |
| Merck Sharp & Dohme LLC | 5 | $106 |
| Novo Nordisk Inc | 4 | $76 |
| ABBVIE INC. | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Amgen Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
Products named: Auvelity, CAPLYTA, VERQUVO, Rybelsus, TRELEGY ELLIPTA, Ozempic, VRAYLAR, TRINTELLIX.
Industry payments across VA — which companies pay providers there.
